| First Author | Daamen AR | Year | 2023 |
| Journal | Front Immunol | Volume | 14 |
| Pages | 1147526 | PubMed ID | 36936908 |
| Mgi Jnum | J:345218 | Mgi Id | MGI:7447705 |
| Doi | 10.3389/fimmu.2023.1147526 | Citation | Daamen AR, et al. (2023) Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients. Front Immunol 14:1147526 |
| abstractText | INTRODUCTION: Pathologic inflammation is a major driver of kidney damage in lupus nephritis (LN), but the immune mechanisms of disease progression and risk factors for end organ damage are poorly understood. METHODS: To characterize molecular profiles through the development of LN, we carried out gene expression analysis of microdissected kidneys from lupus-prone NZM2328 mice. We examined male mice and the congenic NZM2328.R27 strain as a means to define mechanisms associated with resistance to chronic nephritis. Gene expression profiles in lupus mice were compared with those in human LN. RESULTS: NZM2328 mice exhibited progress from acute to transitional and then to chronic glomerulonephritis (GN). Each stage manifested a unique molecular profile. Neither male mice nor R27 mice progressed past the acute GN stage, with the former exhibiting minimal immune infiltration and the latter enrichment of immunoregulatory gene signatures in conjunction with robust kidney tubule cell profiles indicative of resistance to cellular damage. The gene expression profiles of human LN were similar to those noted in the NZM2328 mouse suggesting comparable stages of LN progression. CONCLUSIONS: Overall, this work provides a comprehensive examination of the immune processes involved in progression of murine LN and thus contributes to our understanding of the risk factors for end-stage renal disease. In addition, this work presents a foundation for improved classification of LN and illustrates the applicability of murine models to identify the stages of human disease. |
